Thinking about cancer or dealing with cancer risk can be scary or overwhelming, but we believe that receiving information and resources is comforting, empowering, and lifesaving.
Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Screening (PDQ®) Patient Version
PDQ Screening and Prevention Editorial Board, "Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Screening (PDQ®) Patient Version," December 2016 (Free full text available)
Patient guide to ovarian cancer screening for average risk women.
Use of CA-125 and HE4 serum markers to predict ovarian cancer in elevated-risk women.
Karlan BY, Thorpe J, Urban N, et al. “Use of CA-125 and HE4 serum markers to predict ovarian cancer in elevated-risk women.” Cancer Epidemiology, Biomarkers, and Prevention vol. 23, no. 7 (2014): 1383-93. (Full text available)
The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer
David A. Fishman, Leeber Cohen, Stephanie V. Blank, Lee Shulman, Diljeet Singh, Kenny Bozorgi, Ralph Tamura, Ilan Timor-Tritsch, Peter E. Schwartz. American Journal of Obstetrics and Gynecology. Volume 192, Issue 4: p. 1214-1221, April 2005.
The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
Moore RG, Brown AK, Bast RC, et al. “The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.” Gynecological Oncology vol. 108, no. 2 (2008): 402-8. (Subscription may be required for access to full text)
Biology of Epithelial Ovarian Cancer: Implications for Screening Women at High Genetic Risk
Russell Hogg, Michael Friedlander. Journal of Clinical Oncology. Volume 22, Number 7: p. 1315-1327, April 2004.
Early detection of breast and ovarian cancer in families with BRCA mutations
H.F.A. Vasena, E. Tesfay, H. Boonstra, M.J.E. Mourits, E. Rutgers, R. Verheyen, J. Oosterwijk and L. Beex. European Journal of Cancer. Volume 41, Issue 4: p. 549-554, March 2005.
Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer
Zhen Zhang, Robert C. Bast, Jr., Yinhua Yu, Jinong Li, Lori J. Sokoll, Alex J. Rai, Jason M. Rosenzweig, Bonnie Cameron, Young Y. Wang, Xiao-Ying Meng, Andrew Berchuck, Carolien van Haaften-Day, Neville F. Hacker, Henk W. A. de Bruijn, Ate G. J. van der Zee, Ian J. Jacobs, Eric T. Fung and Daniel W. Chan. Cancer Research. Volume 64, Issue 16: p. 5882-5890, August 2004.
Lysophospholipids Are Potential Biomarkers of Ovarian Cancer
Rebecca Sutphen, Yan Xu, George D. Wilbanks, James Fiorica, Edward C. Grendys, Jr., James P. LaPolla, Hector Arango, Mitchell S. Hoffman, Martin Martino, Katie Wakeley, David Griffin, Rafael W. Blanco, Alan B. Cantor, Yi-jin Xiao and Jeffrey P. Krischer. Cancer Epidemiology Biomarkers & Prevention. Volume 13, Issue 7: p. 1185-1191, July 2004.
Cancer genetics network ovarian screening study: Physician practice patterns in screening women at high risk for ovarian cancer
K. H. Lu, H. Symecko, S. Skates, D. M. Finkelstein. American Society of Clinical Oncologists. 22: p. 490, (abstract # 1972), June 2003. (Annual conference proceedings abstract)
Outcome of Preventive Surgery and Screening for Breast and Ovarian Cancer in BRCA Mutation Carriers
Lauren Scheuer, Noah Kauff, Mark Robson, Bridget Kelly, Richard Barakat, Jaya Satagopan, Nathan Ellis, Martee Hensley, Jeff Boyd, Patrick Borgen, Larry Norton, Kenneth Offit. Journal of Clinical Oncology. Volume 20, Issue 5: p. 1260-1268, March 2002.
Use of proteomic patterns in serum to identify ovarian cancer
Emanuel F Petricoin, III, Ali M Ardekani, Ben A Hitt, Peter J Levine, Vincent A Fusaro, Seth M Steinberg, Gordon B Mills, Charles Simone, David A Fishman, Elise C Kohn and Lance A Liotta. Lancet. Volume 359, Issue 9306: p. 572-577, February 2002.
Transvaginal Sonography as a Screening Method for the Detection of Early Ovarian Cancer
P. D. Depriest, H. H. Gallion,, E. J. Pavlik, R. J. Kryscio and J. R. van Nagell, Jr. Gynecologic Oncology. Volume 65, Issue 3: p. 408-414, June 1997.